2020
NMR in integrated biophysical drug discovery for RAS: past, present, and future
Marshall C, KleinJan F, Gebregiworgis T, Lee K, Fang Z, Eves B, Liu N, Gasmi-Seabrook G, Enomoto M, Ikura M. NMR in integrated biophysical drug discovery for RAS: past, present, and future. Journal Of Biomolecular NMR 2020, 74: 531-554. PMID: 32804298, DOI: 10.1007/s10858-020-00338-6.Peer-Reviewed Original ResearchConceptsGTPase domainProper membrane localizationMultiple signaling cascadesOncogenic Ras mutationsKey downstream effectorDrug discoveryGTPase cycleMembrane localizationRAS proteinsGTP hydrolysisConformational selectionRAS signalingDownstream effectorsSignaling cascadesLipid modificationG12C mutantUpstream regulatorBiophysical approachesSmall proteinsRAS oncogenesDruggable pocketHuman cancersCell growthCovalent inhibitorsPeptidyl inhibitors
2013
Inhibition of Signal Transducer and Activator of Transcription 3 and Cyclooxygenase-2 Is Involved in Radiosensitization of Cepharanthine in HeLa Cells
Fang Z, Li Y, Chen Z, Wang J, Zhu L. Inhibition of Signal Transducer and Activator of Transcription 3 and Cyclooxygenase-2 Is Involved in Radiosensitization of Cepharanthine in HeLa Cells. International Journal Of Gynecological Cancer 2013, 23: 608. PMID: 23466568, DOI: 10.1097/igc.0b013e31828a05fd.Peer-Reviewed Original ResearchConceptsHeLa cellsSignal transducerTranscription 3C-MycSTAT3 target genesCell cycle regulators c-MycBcl-2Antiapoptotic Bcl-2Target genesWestern blot analysisHeLa cell lineApoptosis inductionBlot analysisNude mouse xenograftsCell linesReduced expressionSTAT3Apoptosis analysisMouse xenograftsSignificant radiosensitizationIR treatmentClonogenic assayActivatorCellsCytotoxic effects